Works matching IS 20457634 AND DT 2022 AND VI 11 AND IP 23

Results: 27

Identifying tumor antigens and immuno‐subtyping in colon adenocarcinoma to facilitate the development of mRNA vaccine.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4656, doi. 10.1002/cam4.4846

By:

Tan, Huaicheng;
Yu, Ting;
Liu, Chunhua;
Wang, Yang;
Jing, Fangqi;
Ding, Zhenyu;
Liu, Jiyan;
Shi, Huashan

Publication type:

Article

Oncolytic adenovirus H101 ameliorate the efficacy of anti‐PD‐1 monotherapy in colorectal cancer.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4575, doi. 10.1002/cam4.4845

By:

Huang, Lili;
Zhao, Huaxin;
Shan, Mengying;
Chen, Hong;
Xu, Bin;
He, Yang;
Zhao, Yu;
Liu, Zhuqing;
Chen, Jianhua;
Xu, Qing

Publication type:

Article

Construction and validation of a prognostic model based on 11 lymph node metastasis‐related genes for overall survival in endometrial cancer.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4641, doi. 10.1002/cam4.4844

By:

Wu, Hong;
Feng, Haiqin;
Miao, Xiaoli;
Ma, Jiancai;
Liu, Cairu;
Zhang, Lina;
Yang, Liping

Publication type:

Article

Light‐intensity and moderate‐to‐vigorous intensity physical activity among older adult breast cancer survivors with obesity: A narrative review.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4602, doi. 10.1002/cam4.4841

By:

Gordon, Brett R.;
Caru, Maxime;
Blair, Cindy K.;
Bluethmann, Shirley M.;
Conroy, David E.;
Doerksen, Shawna E.;
Hakun, Jonathon G.;
Sturgeon, Kathleen M.;
Potiaumpai, Melanie;
Sciamanna, Christopher N.;
Schmitz, Kathryn H.

Publication type:

Article

SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4526, doi. 10.1002/cam4.4840

By:

Wang, Meijie;
Sun, Xiaozheng;
Xin, Huixian;
Wen, Zhihua;
Cheng, Yufeng

Publication type:

Article

Clinicopathological characteristics and prognosis of microinvasive breast cancer: A population‐based analysis.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4501, doi. 10.1002/cam4.4839

By:

Xu, Hangcheng;
Han, Yiqun;
Wu, Yun;
Wang, Yan;
Wang, Jiayu;
Xu, Binghe

Publication type:

Article

A novel DNA methylation‐driver gene signature for long‐term survival prediction of hepatitis‐positive hepatocellular carcinoma patients.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4721, doi. 10.1002/cam4.4838

By:

Fu, Jie;
Qin, Wei;
Tong, Qing;
Li, Zhenghao;
Shao, Yaoli;
Liu, Zhiqiang;
Liu, Chun;
Wang, Zicheng;
Xu, Xundi

Publication type:

Article

Performance of subjective global nutritional assessment in predicting clinical outcomes: Data from the Brazilian survey of pediatric oncology nutrition.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4612, doi. 10.1002/cam4.4837

By:

Afonso, Wanélia Vieira;
Peres, Wilza Arantes Ferreira;
de Pinho, Nivaldo Barroso;
Schilithz, Arthur Orlando Corrêa;
Martucci, Renata Brum;
Rodrigues, Viviane Dias;
Nascimento, Barbara Folino;
Moreira, Carolina Ferraz Figueiredo;
de Carvalho Padilha, Patricia

Publication type:

Article

A novel prognostic model for papillary thyroid cancer based on epithelial–mesenchymal transition‐related genes.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4703, doi. 10.1002/cam4.4836

By:

Liu, Rui;
Cao, Zhen;
Pan, Meng;
Wu, Mengwei;
Li, Xiaobin;
Yuan, Hongwei;
Liu, Ziwen

Publication type:

Article

DDX24 promotes metastasis by regulating RPL5 in non‐small cell lung cancer.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4513, doi. 10.1002/cam4.4835

By:

Hu, Xinyan;
Li, Fangfang;
Zhou, Yulan;
Gan, Hairun;
Wang, Tiancheng;
Li, Luting;
Long, Haoyu;
Li, Bing;
Pang, Pengfei

Publication type:

Article

Alectinib versus crizotinib in ALK‐positive advanced non‐small cell lung cancer and comparison of next‐generation TKIs after crizotinib failure: Real‐world evidence.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4491, doi. 10.1002/cam4.4834

By:

Wang, Yurong;
Shen, Shujing;
Hu, Peizhu;
Geng, Di;
Zheng, Ruipan;
Li, Xingya

Publication type:

Article

Childhood cancer survivorship in China: An overview of the past two decades.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4588, doi. 10.1002/cam4.4831

By:

Ji, Xu;
Su, Jun;
Liu, Xinyu;
Mao, Ziling;
Zhang, Wenjing;
Zhang, Jinhe;
Sun, Xiaojie;
Han, Xuesong

Publication type:

Article

Simple IHC reveals complex MMR alternations than PCR assays: Validation by LCM and next‐generation sequencing.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4479, doi. 10.1002/cam4.4832

By:

Amemiya, Kenji;
Hirotsu, Yosuke;
Nagakubo, Yuki;
Watanabe, Shunsuke;
Amemiya, Saki;
Mochizuki, Hitoshi;
Oyama, Toshio;
Kondo, Tetsuo;
Omata, Masao

Publication type:

Article

Estimates of incidence, prevalence, mortality, and disability‐adjusted life years of lung cancer in Iran, 1990–2019: A systematic analysis from the global burden of disease study 2019.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4624, doi. 10.1002/cam4.4792

By:

Shokri Varniab, Zahra;
Sharifnejad Tehrani, Yeganeh;
Pourabhari Langroudi, Ashkan;
Azadnajafabad, Sina;
Rezaei, Negar;
Rashidi, Mohammad‐Mahdi;
Esfahani, Zahra;
Malekpour, Mohammad‐Reza;
Ghasemi, Erfan;
Ghamari, Azin;
Dilmaghani‐Marand, Arezou;
Mohammadi Fateh, Sahar;
Namazi Shabestari, Alireza;
Larijani, Bagher;
Farzadfar, Farshad

Publication type:

Article

Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR‐103b/877‐5p/29c‐5p as diagnostic biomarkers for early lung adenocarcinoma.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4411, doi. 10.1002/cam4.4788

By:

Wu, Jing;
Feng, Zian;
Wang, Rui;
Li, Ang;
Wang, Hong;
He, Xiaodong;
Shen, Zuojun

Publication type:

Article

Neoadjuvant treatment of sintilimab plus hypofractionated radiotherapy for MSI‐H/dMMR rectal cancer: A prospective, multicenter, phase Ib study.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4405, doi. 10.1002/cam4.4720

By:

Li, Xiaofen;
Fang, Chao;
Wang, Xin;
Yu, Yongyang;
Wang, Ziqiang;
Qiu, Meng

Publication type:

Article

Long noncoding RNA GK‐IT1 promotes esophageal squamous cell carcinoma by regulating MAPK1 phosphorylation.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4555, doi. 10.1002/cam4.4795

By:

Yang, Xin;
Zeng, Tianyang;
Liu, Ziyang;
He, Wanlun;
Hu, Mengting;
Tang, Ti;
Chen, Li;
Xing, Lei

Publication type:

Article

Prediction of lung cancer risk in Chinese population with genetic‐environment factor using extreme gradient boosting.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4469, doi. 10.1002/cam4.4800

By:

Li, Yutao;
Zou, Zixiu;
Gao, Zhunyi;
Wang, Yi;
Xiao, Man;
Xu, Chang;
Jiang, Gengxi;
Wang, Haijian;
Jin, Li;
Wang, Jiucun;
Wang, Huai Zhou;
Guo, Shicheng;
Wu, Junjie

Publication type:

Article

Bacteria in cancer therapy: A new generation of weapons.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4457, doi. 10.1002/cam4.4799

By:

Fan, Jun Ying;
Huang, Yuan;
Li, Yi;
Muluh, Tobias Achu;
Fu, Shao Zhi;
Wu, Jing Bo

Publication type:

Article

Cost‐effectiveness of osimertinib versus placebo in resected EGFR‐mutated non‐small cell lung cancer in China.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4449, doi. 10.1002/cam4.4798

By:

Zhou, Xiwen;
Du, Jianting;
Xu, Guobing;
Chen, Chun;
Zheng, Bin;
Chen, Jiahe

Publication type:

Article

Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the United States.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4440, doi. 10.1002/cam4.4797

By:

Emole, Josephine;
Lawal, Odunayo;
Lupak, Oleksandra;
Dias, Ajoy;
Shune, Leyla;
Yusuf, Korede

Publication type:

Article

DIAPH3 is a prognostic biomarker and inhibit colorectal cancer progression through maintaining EGFR degradation.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4688, doi. 10.1002/cam4.4793

By:

Huang, Renli;
Wu, Cheng;
Wen, Jialing;
Yu, Jianyang;
Zhu, Huidong;
Yu, Jinlong;
Zou, Zhaowei

Publication type:

Article

Association of anticoagulant use with clinical outcomes from crizotinib in ALK‐ and ROS1‐rearranged advanced non‐small cell lung cancers: A retrospective analysis of PROFILE 1001.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4422, doi. 10.1002/cam4.4789

By:

Ng, Terry L.;
Tsui, David C. C.;
Wang, Sherry;
Usari, Tiziana;
Patil, Tejas;
Wilner, Keith;
Camidge, David R.

Publication type:

Article

KBTBD7 promotes non‐small cell lung carcinoma progression by enhancing ubiquitin‐dependent degradation of PTEN.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4544, doi. 10.1002/cam4.4794

By:

Zou, Zifang;
Zhang, Bo;
Li, Zhihan;
Lei, Lei;
Sun, Guanghao;
Jiang, Xizi;
Guan, Jingqian;
Zhang, Yao;
Xu, Shun;
Li, Qingchang

Publication type:

Article

Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4673, doi. 10.1002/cam4.4791

By:

Zhu, Guang‐Li;
Yang, Kai‐Bin;
Xu, Cheng;
Feng, Rui‐Jia;
Li, Wen‐Fei;
Ma, Jun

Publication type:

Article

Issue Information.

Published in:: Cancer Medicine, 2022, v. 11, n. 23, p. 4399, doi. 10.1002/cam4.4010
Publication type:: Article

Locoregional recurrence after nephrectomy for localized renal cell carcinoma: Feasibility and outcomes of different treatment modalities.

Published in:

Cancer Medicine, 2022, v. 11, n. 23, p. 4430, doi. 10.1002/cam4.4790

By:

Liu, Yang;
Zhang, Xinyue;
Ma, Huali;
Tian, Li;
Mai, Lixin;
Long, Wen;
Zhang, Zhiling;
Han, Hui;
Zhou, Fangjian;
Dong, Pei;
He, Liru

Publication type:

Article